DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 570,000 | $11,970,000 | 0.24% |
| Casdin Capital, LLC | 370,000 | $7,770,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $2,100,000 | 0.19% |
| Artal Group S.A. | 300,000 | $6,300,000 | 0.14% |
| HARVARD MANAGEMENT CO INC | 107,252 | $2,252,000 | 0.12% |
| HHLR ADVISORS, LTD. | 600,000 | $12,600,000 | 0.10% |
| Perceptive Advisors | 400,000 | $8,400,000 | 0.09% |
| Orbimed Advisors | 350,000 | $7,350,000 | 0.06% |
| CAAS CAPITAL MANAGEMENT LP | 185,911 | $3,904,000 | 0.04% |
| Alyeska Investment Group, L.P. | 78,566 | $1,650,000 | 0.02% |
External links
This page lists DYNE THERAPEUTICS INC's shareholders in Q4 2020. To view DYNE THERAPEUTICS INC's shareholder history, click here.